(訂正)「TCG2509株式会社による当社株式に対する公開買付けに関する賛同の意見表明及び応募推奨のお知らせ」の訂正に関するお知らせ
ホギメディ (35930)
- Dartong Group (27.58%) and GMO (10.38%) agreed to sell all shares in HogimeDI at ¥6,700 each.
- Lower limit for Carillon Fund’s purchase is 14,362,400 shares (66.62%).
- Dartong Group and GMO can acquire up to 20% and 5%, respectively, in a future Limited Partnership fund at the same price.
- HogimeDI supports TCG2509’s tender offer.
- Tender deadline extended to Jan 31, 2026.